lncRNA LINC00960 promotes apoptosis by sponging ubiquitin ligase Nrdp1-targeting miR-183-5p

Hao Yang1,2, Tianxia Jiang2, Libin Fan1

  • 1College of Life Sciences, Anhui Medical University, Hefei 230032, China.

Insights

The long noncoding RNA LINC00960 promotes apoptosis by inhibiting miR-183-5p, which normally downregulates Nrdp1. This pathway impacts cancer and neurodegenerative diseases.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Death Research

Background:

  • The ubiquitin ligase Nrdp1/RNF41 targets substrates like BRUCE/BIRC6, regulating apoptosis and autophagy.
  • MicroRNA miR-183-5p is implicated in malignancies and targets numerous genes, including Nrdp1 mRNA.
  • Long noncoding RNA LINC00960's role in regulating gene expression and apoptosis is under investigation.

Purpose of the Study:

  • To investigate the regulatory relationship between LINC00960, miR-183-5p, and Nrdp1 in the context of apoptosis.
  • To determine the functional impact of this regulatory axis on apoptosis and its potential relevance in diseases like cancer.

Main Methods:

  • Quantitative PCR to analyze gene expression levels of LINC00960, miR-183-5p, and Nrdp1 in tumor cell lines.
  • Luciferase reporter assays to confirm the binding of miR-183-5p to the 3'UTR of Nrdp1 mRNA.
  • Overexpression and knockdown experiments to assess the functional effects of LINC00960 and miR-183-5p on Nrdp1 levels and apoptosis.

Main Results:

  • miR-183-5p directly targets Nrdp1 mRNA, downregulating its expression and inhibiting apoptosis.
  • LINC00960 binds to miR-183-5p, inhibiting its activity and consequently upregulating Nrdp1 and promoting apoptosis.
  • Expression levels of LINC00960 positively correlate with Nrdp1 and inversely with miR-183-5p in human tumor samples.

Conclusions:

  • LINC00960 acts as a tumor suppressor by upregulating Nrdp1 and promoting apoptosis via inhibition of miR-183-5p.
  • This LINC00960/miR-183-5p/Nrdp1 axis represents a novel regulatory mechanism in apoptosis.
  • Findings suggest potential therapeutic strategies for apoptosis-related diseases, including cancers and neurodegenerative disorders.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K